title: Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
authors.forename: J H
authors.initials: JH
authors.lastname: Edmonson
authors.forename: H J
authors.initials: HJ
authors.lastname: Long
authors.forename: J A
authors.initials: JA
authors.lastname: Jeffries
authors.forename: J C
authors.initials: JC
authors.lastname: Buckner
authors.forename: G
authors.initials: G
authors.lastname: Colon-Otero
authors.forename: T R
authors.initials: TR
authors.lastname: Fitch
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D016190:Carboplatin; D003115:Colony-Stimulating Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006098:Granulocytes; D006133:Growth Substances / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008264:Macrophages; D009944:Organoplatinum Compounds / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D009944:Organoplatinum Compounds; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016190:Carboplatin